NVO - Novo Nordisk
Close
82.69
-0.400 -0.484%
Share volume: 251,656
Last Updated: Tue 07 Jan 2025 08:30:08 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$83.09
-0.40
-0.48%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |